Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone vs Risperidone in Schizophrenia
NCT02002832Phase 3Completed
- Sponsor
- Sumitomo Pharma
- Start
- Dec 2013
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lurasidone in schizophrenia, sponsored by Sumitomo Pharma. Started Dec 2013; status: completed.
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02002832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02002832.